Cargando…
Salivary α‐Synuclein RT‐QuIC Correlates with Disease Severity in de novo Parkinson's Disease
Autores principales: | Vivacqua, Giorgio, Mason, Matthew, De Bartolo, Maria Ilenia, Węgrzynowicz, Michal, Calò, Laura, Belvisi, Daniele, Suppa, Antonio, Fabbrini, Giovanni, Berardelli, Alfredo, Spillantini, MariaGrazia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092811/ https://www.ncbi.nlm.nih.gov/pubmed/36259554 http://dx.doi.org/10.1002/mds.29246 |
Ejemplares similares
-
Alpha‐synuclein RT‐QuIC in the CSF of patients with alpha‐synucleinopathies
por: Fairfoul, Graham, et al.
Publicado: (2016) -
α‐synuclein RT‐QuIC in cerebrospinal fluid of LRRK2‐linked Parkinson's disease
por: Garrido, Alicia, et al.
Publicado: (2019) -
Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease
por: Hall, Sara, et al.
Publicado: (2022) -
RT‐QuIC Detection of Pathological α‐Synuclein in Skin Punches of Patients with Lewy Body Disease
por: Mammana, Angela, et al.
Publicado: (2021) -
Identification
of α-Synuclein Proaggregator:
Rapid Synthesis and Streamlining RT-QuIC Assays in Parkinson’s
Disease
por: Takada, Fumito, et al.
Publicado: (2022)